Ingenix
Builds AI architecture fusing biological data modalities to accelerate pharma and biotech drug development
€13MSeed+
Role not disclosedIV
Inovo VC
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Inovo VC is the venture investor named in Ingenix and Creem financing material, with Creem identifying a lead relationship.
Recorded funding activity
Creem supplies merchant-of-record checkout, tax and payments infrastructure for software sellers. Ingenix combines biological data modalities for drug-development work. These companies serve different customers and retain separate financing events.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $15.1M 1 disclosed · full round size, not this investor’s share